Systemic lupus erythematosus complicated by acquired von Willebrand's syndrome

Lupus. 2008 Sep;17(9):846-8. doi: 10.1177/0961203308089429.

Abstract

Haematological abnormalities are common in systemic lupus erythematosus (SLE). In some cases of acquired von Willebrand syndrome (AvWS), von Willebrand disease (vWD) is associated with autoimmune or lymphoproliferative disorders. In this study, we describe a 36-year-old woman with SLE and AvWS. The patient was referred to our hospital because of easy bruisability and recurrent vaginal bleeding. She had no history of bleeding tendency and no family history of bleeding diathesis, but she had a history of recurrent arthralgia, photosensitivity and sicca symptoms. Tests for antinuclear, anti-double stranded DNA, anticardiolipin and anti-beta2-glycoprotein I antibodies were all positive. Analysis of haemostatic parameters showed complete absence of von Willebrand factor ristocetin cofactor (vWF:Rco), von Willebrand antigen (vWF:Ag) and ristocetin-induced platelet aggregation (RIPA). Electrophoretic analysis of plasma showed a complete absence of high-molecular weight vWF multimer. The presence of antibody to vWF was detected by enzyme linked immunosorbent assay (ELISA). Treatment with corticosteroids improved SLE symptoms and corrected bleeding diasthesis. Also, the multimeric patterns of vWF became normalised and anti-vWF antibody disappeared. These findings indicated that this patient had SLE associated with AvWS, which was ameliorated by corticosteroid treatment.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Autoantibodies / blood
  • Female
  • Glucocorticoids / therapeutic use
  • Hemorrhage / diagnosis
  • Hemorrhage / etiology
  • Humans
  • Lupus Erythematosus, Systemic / complications*
  • Lupus Erythematosus, Systemic / diagnosis*
  • Lupus Erythematosus, Systemic / drug therapy
  • von Willebrand Diseases / complications*
  • von Willebrand Diseases / diagnosis*
  • von Willebrand Diseases / drug therapy
  • von Willebrand Factor / immunology

Substances

  • Autoantibodies
  • Glucocorticoids
  • von Willebrand Factor